Annual Drug Patent Expirations for LIDOSITE+TOPICAL+SYSTEM+KIT Lidosite Topical System Kit is a drug marketed by Vyteris and is included in one NDA. There is one patent protecting this drug. This…
The post New patent expiration for Vyteris drug LIDOSIT…
New patent expiration for Vyteris drug LIDOSITE TOPICAL SYSTEM KIT Read Post »
Annual Drug Patent Expirations for NUZYRA Nuzyra is a drug marketed by Paratek Pharms Inc and is included in two NDAs. There are eleven patents protecting this drug. This drug…
The post New patent expiration for Paratek Pharms drug NUZYRA appeared firs…
New patent expiration for Paratek Pharms drug NUZYRA Read Post »
Annual Drug Patent Expirations for EPANED Epaned is a drug marketed by Azurity and Silvergate Pharms and is included in two NDAs. It is available from one supplier. There are…
The post New patent for Azurity drug EPANED appeared first on DrugPatentWatc…
Pharmaceutical drug patents enable branded drug companies to prevent market entry by competitors until the patents expire. The term of drug patents varies. The basic term for a patent is…
The post Future drug patent expirations by year appeared first o…
Annual Drug Patent Expirations for SUSTOL Sustol is a drug marketed by Heron Theraps Inc and is included in one NDA. It is available from one supplier. There are seven…
The post New patent expiration for Heron Theraps drug SUSTOL appeared first on Drug…
New patent expiration for Heron Theraps drug SUSTOL Read Post »
Annual Drug Patent Expirations for FERRIPROX Ferriprox is a drug marketed by Chiesi and is included in three NDAs. It is available from two suppliers. There are five patents protecting…
The post New patent expiration for Chiesi drug FERRIPROX appeared …
Annual Drug Patent Expirations for VYLEESI+%28AUTOINJECTOR%29 Vyleesi (autoinjector) is a drug marketed by Palatin Technologies and is included in one NDA. It is available from one supplier. There are five…
The post New patent expiration for Palatin Te…
New patent expiration for Palatin Technologies drug VYLEESI (AUTOINJECTOR) Read Post »
SEEBRI (glycopyrrolate) Novartis Patent: 9,962,338 Expiration: Jun 27, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug …
Drug Patent Expirations for the Week of June 27, 2021 Read Post »
This chart shows the pharmaceutical companies with the most patents in Sweden. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug paten…
Which pharmaceutical companies have the most drug patents in Sweden? Read Post »
Annual Drug Patent Expirations for UTIBRON Utibron is a drug marketed by Novartis and is included in one NDA. There are thirteen patents protecting this drug. Drug patent litigation for…
The post New patent expiration for Novartis drug UTIBRON appeared…
Get new actionable insights and updates from BiotechBlog
